Blood cancer patients to benefit from £3k-a-dose Trojan Horse drug - Daily Mail

The drug, Polivy, acts as a Trojan Horse targeting blood cancer cells. The targeted treatment cuts the risk of the disease returning to patients by as much as a quarter.

Thousands of blood cancer patients could receive a Trojan horse drug which hunts out tumour cells and destroys them from the inside, after UK regulators gave the medication the green light last week.… [+2643 chars]

full article...